From Molecules to Medicine: New Horizons in Vascular Biology and Thrombosis

 

^* The author is president of the 52^nd GTH-Congress in Wiesbaden, Germany, February 20–23, 2008.

• References

• 1 Nurden P, Nurden AT. Congenital disorders associated with platelet dysfuntions. Thromb Haemost 2008; 99: 253-263.
• 2 Bergmeier W, Chauhan AK, Wagner DD. Glycoprotein Ibα and von Willebrand factor in primary platelet adhesion and thrombus formation: lessons from mutant mice. Thromb Haemost 2008; 99: 264-270.
• 3 Denis CV, Christophe OD, Orrtwijn BD. et al. Clearance of von Willebrand factor. Thromb Haemost 2008; 99: 271-278.
• 4 Barberis L, Hirsch E. Targeting Phosphoinositide 3-kinase γ to fight inflammation and more. Thromb Haemost 2008; 99: 279-285.
• 5 Hirsch E, Katanaev VL, Garlanda C. et al. Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science 2000; 287: 1049-1053.
• 6 Kanse SM, Parahuleva M, Muhl L. et al. Factor VII activating protease (FSAP): Vascular functions and role in atheroschlerosis. Thromb Haemost 2008; 99: 286-289.
• 7 Samad F, Loskutoff DJ. The fat mouse: a powerful genetic model to study elevated plasminogen activator inhibitor 1 in obesity/NIDDM. Thromb Haemost 1997; 78: 652-655.
• 8 Christiaens V, Scroyen I, Lijnen HR. Role of proteolysis in development of murine adipose tissue. Thromb Haemost 2008; 99: 290-294.
• 9 Hughes M, Lip GYH. Stroke and thromboembolism in atrial fibrillation: A schematic review of stroke risk factors, risk stratification schema and cost effectiveness data. Thromb Haemost 2008; 99: 295-304.